Nina Capital, a Barcelona-based VC firm dedicated to healthcare transformation through technology, announces the first close of its €50 million Fund III, propelling total assets under management to over €100 million.
Fund III is anchored by contributions from limited partners such as Boston-based wealth management firm Seven Two Partners, professional family offices, foundations, corporations, and individuals across Europe and the United States.
“Healthcare is at an inflection point. We see extraordinary opportunities for innovation to break down inefficiencies, increase access, and improve outcomes. Fund III solidifies our commitment to finding and supporting the boldest minds tackling healthcare’s most urgent challenges,” said Dr Marta G. Zanchi, Founder and Managing Director at Nina Capital. “Our mission is clear: to find and support the founders who are solving timely and compelling healthcare needs, blending technology innovation with sound business models built on a solid understanding of healthcare market incentives and constraints.”
Founded in 2019 by Dr Marta G. Zanchi, Nina Capital is set to build a new portfolio of investments across Europe, North America, Israel, and, for the first time, Australia with Fund III. From pre-Seed to Series A, the fund will write initial checks ranging from €250k to €1.5 million, with reserves to support portfolio companies through follow-on funding.
Building on the success of its previous funds, Nina Capital has already made its first Fund III investment: Sonar Mental Health, a US-based mental health platform serving school districts nationwide that assists students through a combination of AI and human-led support. With two more investments in the pipeline for early 2025, Fund III reflects Nina Capital’s interest in technologies that create meaningful, measurable healthcare impact.
According to Nina Capital, startups from Fund I achieved an above 80% graduation rate from seed to the next stage, while Fund II portfolio companies collectively grew revenue almost 5x within two years from the initial investment.
Dr Marta G. Zanchi, a former director of Stanford Biodesign’s Digital Health initiatives and medical technology executive, and Marc Subirats, an accomplished entrepreneur whose telemedicine company Advance Medical was acquired by Teladoc Health, bring relevant hands-on experience to their roles as General Partners. “This fund is the next natural chapter of our story, building on a proven strategy and team,” said Subirats.
Like previous funds, Fund III will focus on three critical healthtech areas:
- Clinical Innovation and Education – Empowering new solutions in diagnostics, medical devices, and clinician training.
- Healthcare Infrastructure – Transforming data-driven processes in preclinical R&D, clinical trials, pharmaceutical logistics, and manufacturing.
- Clinical Pathways and Health Data – Improving care delivery through tech-enabled services and operational efficiencies.
“Healthcare is at the forefront of a transformative era, where groundbreaking innovations are creating immense opportunities for both patient impact and investors,” said Andrew Macken, Managing Partner at Seven Two. “For the best outcomes in this complex industry, we believe that it is important for managers to find great founders who are working on solving these significant problems and for those managers to help these businesses grow. We are impressed with the work that Marta and her team have accomplished and excited to see what Nina Capital has in store to reshape the future of healthcare.”
Read the orginal article: https://www.eu-startups.com/2025/02/female-founded-healthtech-vc-firm-nina-capital-closes-e50-million-fund-iii/
